Deep within the skeletal architecture of the human body, bone marrow operates as the primary engine of human hematopoiesis. This…
Read More
Precision Nanomedicine Targeting Immune Dysregulation Shows Preclinical Promise for Endometriosis Using Repurposed Anthelmintic Drug
Endometriosis remains one of the most enigmatic and debilitating gynecological conditions affecting individuals of reproductive age worldwide. Characterized by the…
Read More
The biotech bi-weekly: an expansion into cardiac drug discovery, the world’s largest healthy human protein atlas and large libraries of AI-designed proteins
The global biotechnology sector continues to experience rapid advancements across multiple disciplines, ranging from fundamental laboratory tools to advanced artificial…
Read More
Dual-Drug Therapy Breakthrough Offers New Hope for Acute Myelogenous Leukemia Patients in Landmark Ludwig Cancer Research Study
Acute myelogenous leukemia (AML) remains one of the most formidable and aggressive malignancies in modern oncology. Characterized by rapid progression…
Read More
Daiichi Sankyo and Merck Voluntarily Withdraw US Application for Lung Cancer Drug Ifinatamab Deruxtecan Following FDA Discussions
Pharmaceutical giants Daiichi Sankyo and Merck & Co., known globally as MSD, have officially announced the voluntary withdrawal of their…
Read More
Enveda Biosciences Secures $311m in Series E Funding to Accelerate AI-Powered Natural Drug Discovery Pipeline
Colorado-based biotechnology pioneer Enveda Biosciences has officially closed a substantial $311m Series E financing round, bringing its cumulative venture backing…
Read More
The oral exposure challenge in PROTACs: What drug developers need to solve early
The landscape of modern pharmacology shifted fundamentally in May 2026 with the U.S. Food and Drug Administration’s approval of vepdegestrant,…
Read More
2026 PharmSci 360 adds tracks on research credibility and post-animal drug development
The American Association of Pharmaceutical Scientists (AAPS) has announced a significant evolution for its flagship annual conference, PharmSci 360, which…
Read More
ELRIG Drug Discovery 2026 Marks Two Decades of Innovation as Europe’s Premier Life Sciences Event Returns to London
The European Laboratory Research and Innovation Group (ELRIG) is preparing to host its flagship milestone event, ELRIG Drug Discovery 2026,…
Read More
A plate of spaghetti: Talus Bio boasts 5,000-fold faster drug screening by skipping protein folding
The landscape of modern pharmacology has been fundamentally reshaped by the advent of artificial intelligence, most notably by the breakthrough…
Read More
